15 days agoThe application for the new generation of pan TRK inhibitor Zurletrectinib (ICP-seven hundred and twDTnewswire
14 days agoThe application for the new generation of pan TRK inhibitor Zurletrectinib (ICP-seven hundred and twDTnewswire
29 days agoExcessive Impulse Regret Cycle: Repeatedly Choosing Beyond One’s Limits Followed by Guiltaiworkedit
5 days agoInnoCare Pharma Yinuokai (Obutinib) has been approved as a first-line treatment for chronic lymphocyDTnewswire